Trevena Announces Positive Topline OLINVYK Cognitive Function Data and Provides General Business Update Jul 28, 2022 7:00 am EDT
Trevena Announces the Publication of an Expert Review on the Clinical Profile of OLINVYK® in Post-Operative Care Jun 14, 2022 7:00 am EDT
Trevena Announces Results from Respiratory Physiology Study of Head-to-Head Comparison of OLINVYK® and IV Morphine in Elderly/Overweight Subjects Apr 20, 2022 7:00 am EDT
Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with R-Bridge Healthcare Fund Apr 18, 2022 7:00 am EDT
OLINVYK® data selected as President’s Choice abstract at Annual Regional Anesthesiology and Acute Pain Medicine Meeting and Featured at American Burn Association Annual Meeting Apr 13, 2022 4:05 pm EDT